Global Wealth Management Investment Advisory’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-12
Closed -$1.46K – 459
2023
Q4
$1.46K Hold
12
– – ﹤0.01% 419
2023
Q3
$1.35K Hold
12
– – ﹤0.01% 411
2023
Q2
$1.75K Buy
+12
New +$1.63K ﹤0.01% 396
2022
Q3
– Sell
-12
Closed -$1K – 500
2022
Q2
$1K Hold
12
– – ﹤0.01% 490
2022
Q1
$2K Sell
12
-100
-89% -$12.1K ﹤0.01% 439
2021
Q4
$14K Buy
112
+100
+833% +$13.1K ﹤0.01% 284
2021
Q3
$2K Hold
12
– – ﹤0.01% 432
2021
Q2
$2K Hold
12
– – ﹤0.01% 409
2021
Q1
$2K Hold
12
– – ﹤0.01% 428
2020
Q4
$2K Hold
12
– – ﹤0.01% 412
2020
Q3
$2K Hold
12
– – ﹤0.01% 402
2020
Q2
$1K Hold
12
– – ﹤0.01% 590
2020
Q1
$1K Hold
12
– – ﹤0.01% 585
2019
Q4
$2K Buy
12
+2
+20% +$276 ﹤0.01% 538
2019
Q3
$1K Hold
10
– – ﹤0.01% 619
2019
Q2
$1K Hold
10
– – ﹤0.01% 670
2019
Q1
$1K Hold
10
– – ﹤0.01% 660
2018
Q4
$1K Buy
+10
New +$1.13K ﹤0.01% 683

Other funds holding ZBH

Global Wealth Management Investment Advisory's ZBH Position: Q1 2024 in Review

Global Wealth Management Investment Advisory sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 12 shares — an estimated $1.46K sold.

Global Wealth Management Investment Advisory first reported a position in ZBH in Q4 2018 and held it in 18 quarters. The position peaked at $14K in Q4 2021. 1,014 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Global Wealth Management Investment Advisory reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 12 Zimmer Biomet shares in Q1 2024, an estimated $1.46K.
  • Global Wealth Management Investment Advisory first reported a position in Zimmer Biomet in Q4 2018 and held it in 18 quarters.
  • Global Wealth Management Investment Advisory's Zimmer Biomet position peaked at $14K in Q4 2021.
  • 1,014 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2024, filed 10 May 2024.